FDA Action On MDMA Gives New Hope To Researchers And Victims Of PTSD

For the first time ever, with the recent FDA approval, psychedelic-assisted psychotherapy will be evaluated in Phase 3 trials for possible prescription use, with MDMA-assisted psychotherapy for PTSD leading the way.